NEW YORK (GenomeWeb News) — Affymetrix is launching a program to fund microarray-related cancer research at European research centers, the company said today.

 

Under the Collaborations in Cancer Research Program, Affymetrix said it will financially support “selected research projects” that use a variety of microarray-based applications and that are aimed at developing new understanding and discoveries in 10 types of cancer.